23andMe Holding Co. (NASDAQ:ME) Q1 2023 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Wade Walke - Vice President, Investor Relations Anne Wojcicki - Chief Executive Officer & Co-Founder Steve Schoch - Chief Financial Officer Kenneth Hillan - Chief Therapeutics Officer Conference Call Participants Tiago Fauth - Credit Suisse David Lebowitz - Citi Operator Good morning, and welcome to 23andMe's Fiscal 2023 First Quarter Financial Results Conference Call. As a reminder this call is b ...